A detailed history of Advisor Net Financial, Inc transactions in Incyte Corp stock. As of the latest transaction made, Advisor Net Financial, Inc holds 3,169 shares of INCY stock, worth $225,157. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,169
Previous 3,524 10.07%
Holding current value
$225,157
Previous $213,000 1.88%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$57.33 - $68.61 $20,352 - $24,356
-355 Reduced 10.07%
3,169 $209,000
Q2 2024

Jul 16, 2024

SELL
$51.18 - $63.75 $25,487 - $31,747
-498 Reduced 12.38%
3,524 $213,000
Q1 2024

Apr 12, 2024

BUY
$56.55 - $66.59 $565 - $665
10 Added 0.25%
4,022 $229,000
Q4 2023

Jan 19, 2024

BUY
$52.16 - $64.19 $1,877 - $2,310
36 Added 0.91%
4,012 $251,000
Q3 2023

Oct 12, 2023

SELL
$57.77 - $65.93 $1,270 - $1,450
-22 Reduced 0.55%
3,976 $229,000
Q2 2023

Jul 14, 2023

BUY
$60.95 - $75.51 $853 - $1,057
14 Added 0.35%
3,998 $248,000
Q1 2023

Apr 28, 2023

SELL
$70.23 - $86.01 $11,377 - $13,933
-162 Reduced 3.91%
3,984 $287,000
Q4 2022

Jan 13, 2023

BUY
$67.18 - $84.11 $1,612 - $2,018
24 Added 0.58%
4,146 $0
Q3 2022

Oct 04, 2022

BUY
$66.18 - $82.86 $330 - $414
5 Added 0.12%
4,122 $275,000
Q2 2022

Jul 07, 2022

BUY
$66.18 - $83.18 $992 - $1,247
15 Added 0.37%
4,117 $313,000
Q1 2022

Apr 14, 2022

BUY
$66.02 - $79.71 $4,291 - $5,181
65 Added 1.61%
4,102 $326,000
Q3 2021

Oct 15, 2021

BUY
$68.67 - $84.02 $8,583 - $10,502
125 Added 3.2%
4,037 $278,000
Q2 2021

Jul 06, 2021

BUY
$79.87 - $87.53 $4,392 - $4,814
55 Added 1.43%
3,912 $329,000
Q3 2019

Oct 23, 2019

SELL
$72.82 - $86.52 $15,510 - $18,428
-213 Reduced 5.23%
3,857 $286,000
Q2 2019

Jul 15, 2019

SELL
$73.52 - $88.7 $49,478 - $59,695
-673 Reduced 14.19%
4,070 $346,000
Q4 2017

Feb 27, 2018

BUY
$93.56 - $116.6 $443,755 - $553,033
4,743
4,743 $449,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.